This is the PrivCo Investor Profile for 5AM Ventures
This profile is intended to help you find and contact investors, see private market deal activity, and view private company ownership for the investor 5AM Ventures.
To unlock all information in this profile: Upgrade to PrivCo Premium

5AM Ventures

What's included with your PrivCo Premium Subscription:
Next Actions on 5AM Ventures:
View Deal ActivityView Direct E-mail Contacts

Investor Summary

5AM Ventures is a Menlo Park, California-based venture capital firm. Founded in 2002, 5AM Ventures considers seed and early stage investments.

Investor Overview

Basic Information

Investor Type:Venture Capital
Year Founded:2002
Address:2200 Sand Hill Road
Suite 110
City:Menlo Park
State/Province:California
Country:United States
Phone:View
Fax:View
Website:www.5amventures.com

Investment Preferences

Preferred Stage:Seed
Early Stage
Mid Stage / Expansion

Investor Contacts

Below are direct e-mail contacts for senior professionals at 5AM Ventures.
Full contact details are available with a PrivCo Premium Subscription.
Upgrade to PrivCo Premium Subscription Instant Full Site-Wide Access
Currently 50% Off Until May. 31!
NameTitle
Jenny M. LeeVP, Finance
James W. YoungVenture Partner
Mason FreemanVenture Partner
Richard UlevitchVenture Partner
Kevin M. ForrestPrincipal
Mark S. ColellaPrincipal
Andrew McMillanPrincipal
John D. DiekmanManaging Partner
Andrew J. SchwabManaging Partner
Scott M. RocklageManaging Partner

Private Deal History

This table is intended to portray 5AM Ventures PrivCo-covered market activity. Click below for Deal Details and Private Company Reports.
All data before 2006 is completely free to view! To access data from 2006 onward:
Upgrade to PrivCo Premium Subscription Instant Full Site-Wide Access
Currently 50% Off Until May. 31!
DateTargetTarget IndustryDeal TypeTotal Deal AmountStatus
Mar. 2013ViewPharmaceuticalsFundingViewCompletedDetails
Jan. 2013ViewSurgical Equipment & InstrumentsFundingViewCompletedDetails
Dec. 2012ViewBiopharmaceuticalsAcquisitionViewCompletedDetails
Dec. 2012ViewBiotechnologyFundingViewCompletedDetails
Nov. 2012ViewBiotherapeutics
Pharmaceuticals		FundingViewCompletedDetails
Nov. 2012ViewPharmaceutical Research & Drug DiscoveryAcquisition of Remaining Interest
Acquisition		ViewCompletedDetails
Aug. 2012ViewPharmaceuticalsFundingViewCompletedDetails
Aug. 2012ViewBiopharmaceuticalsFundingViewCompletedDetails
Aug. 2012ViewClinical Research Services
Pharmaceuticals		FundingViewCompletedDetails
Jun. 2012ViewOther BiotechnologyAcquisitionViewCompletedDetails
Jun. 2012ViewBiotherapeuticsFundingViewCompletedDetails
Jun. 2012ViewChemical Manufacturing
Other Pharmaceuticals		FundingViewCompletedDetails
Dec. 2011ViewChemical Manufacturing
Other Pharmaceuticals		FundingViewCompletedDetails
Oct. 2011ViewPharmaceutical Research & Drug DiscoveryFundingViewCompletedDetails
Sep. 2011ViewMedical Diagnostic TechnologyFundingViewCompletedDetails
Aug. 2011ViewBiotherapeutics
Pharmaceuticals		FundingViewCompletedDetails
Jul. 2011ViewBiotechnologyFundingViewCompletedDetails
May. 2011ViewChemical Manufacturing
Other Pharmaceuticals		FundingViewCompletedDetails
Mar. 2011ViewBiotechnologyFundingViewCompletedDetails
Dec. 2010ViewMedical Devices & EquipmentFundingViewCompletedDetails
Dec. 2010ViewBiotechnologyFundingViewCompletedDetails
Dec. 2010ViewBiotechnologyAcquisitionViewCompletedDetails
Dec. 2010ViewBiotechnologyFundingViewCompletedDetails
Dec. 2010ViewOther BiotechnologyFundingViewCompletedDetails
Oct. 2010ViewBiotherapeutics
Pharmaceuticals		FundingViewCompletedDetails
Oct. 2010ViewPharmaceutical Research & Drug DiscoveryFundingViewCompletedDetails
Oct. 2010ViewBiotechnologyFundingViewCompletedDetails
Oct. 2010ViewSurgical Equipment & InstrumentsFundingViewCompletedDetails
Sep. 2010ViewBiopharmaceuticalsFundingViewCompletedDetails
Jun. 2010ViewBiopharmaceuticalsFundingViewCompletedDetails
Jun. 2010ViewBiotherapeuticsFundingViewCompletedDetails
May. 2010ViewChemical Manufacturing
Other Pharmaceuticals		FundingViewCompletedDetails
Apr. 2010ViewBiotechnologyFundingViewCompletedDetails
Apr. 2010ViewMedical Diagnostic TechnologyFundingViewCompletedDetails
Apr. 2010ViewMedical Device Design & ManufacturingFundingViewCompletedDetails
Mar. 2010ViewPharmaceuticalsFundingViewCompletedDetails
Nov. 2009ViewBiotherapeutics
Pharmaceuticals		FundingViewCompletedDetails
Oct. 2009ViewBiotechnologyFundingViewCompletedDetails
Sep. 2009ViewChemical Manufacturing
Other Pharmaceuticals		FundingViewCompletedDetails
Apr. 2009ViewMedical Devices & EquipmentFundingViewCompletedDetails
Apr. 2009ViewBiotechnologyFundingViewCompletedDetails
Mar. 2009ViewBiotherapeutics
Pharmaceuticals		FundingViewCompletedDetails
Jan. 2009ViewMedical Device Design & ManufacturingFundingViewCompletedDetails
Jan. 2009ViewPharmaceutical Research & Drug DiscoveryFundingViewCompletedDetails
Dec. 2008ViewBiotherapeuticsFundingViewCompletedDetails
Dec. 2008ViewBiotherapeuticsFundingViewCompletedDetails
Dec. 2008ViewOther BiotechnologyFundingViewCompletedDetails
Jul. 2008ViewBiotherapeutics
Pharmaceuticals		FundingViewCompletedDetails
Feb. 2008ViewBiotechnologyFundingViewCompletedDetails
Dec. 2007ViewBiotechnologyFundingViewCompletedDetails
Oct. 2007ViewBiopharmaceuticalsFundingViewCompletedDetails
Sep. 2007ViewBiotherapeutics
Pharmaceuticals		FundingViewCompletedDetails
Jul. 2007ViewBiotherapeuticsFundingViewCompletedDetails
May. 2007ViewBiotechnologyFundingViewCompletedDetails
Jan. 2007ViewBiotechnologyFundingViewCompletedDetails
Oct. 2006ViewBiotechnologyFundingViewCompletedDetails
Aug. 2006ViewBiotherapeuticsAcquisitionViewCompletedDetails
Mar. 2006ViewBiotechnologyFundingViewCompletedDetails
Mar. 2005KaloBios Pharmaceuticals, Inc.BiotherapeuticsFunding$15,800,000CompletedDetails
Jun. 2004KaloBios Pharmaceuticals, Inc.BiotherapeuticsFunding$10,590,000CompletedDetails

Supplemental Resources

For additional information on 5AM Ventures, or on private company investing, you can see the following:
What's included with your PrivCo Premium Subscription:
Next Actions on 5AM Ventures:
View Deal ActivityView Direct E-mail Contacts
  • Learn More About PrivCo
  • PrivCo’s Clients Include:
  • Clients Include: Motorola, 3M, Samsung, Oracle, TATA, Johnson and Johnson, CB Richard Ellis
  • PrivCo Is Featured In:
  • Featured In: The New York Times, New York Post, Bloomberg, CNBC, NPR, The Washington Post, The Wall Street Journal, CNN, Fortune, BusinessWeek, Reuters, CBS News, USA Today
PrivCo’s 300-page Private Company Tech M&A Report for 2012 - Click Here For Full Report
  • Quick Investor Search

within miles
Go to Advanced Search
  • What is PrivCo?

PrivCo is the authority for financial & business data on major private market investors, including:

PrivCo Private Deals Newsletter.
It's FREE!

This is the PrivCo Investor Profile for 5AM Ventures
This profile is intended to help you find and contact investors, see private market deal activity, and view private company ownership for the investor 5AM Ventures.
To unlock all information in this profile: Upgrade to PrivCo Premium